» Articles » PMID: 33128246

FIGO/ICM Guidelines for Preventing Rhesus Disease: A Call to Action

Overview
Publisher Wiley
Date 2020 Oct 31
PMID 33128246
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti-Rh(D) immunoglobulin. Taking into account the effectiveness anti-Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication.

Citing Articles

Knowledge about Rh-incompatibility and its associated factors among antenatal care recipients in public hospitals of Wolaita zone, 2022: facility-based cross-sectional study.

Geta T, Atinafu B, Kassa T BMJ Public Health. 2025; 2(1):e000422.

PMID: 40018202 PMC: 11812781. DOI: 10.1136/bmjph-2023-000422.


General anaesthesia for nonobstetric surgery during pregnancy: A narrative review.

Bleeser T, Vally J, Van de Velde M, Rex S, Devroe S Eur J Anaesthesiol Intensive Care. 2025; 1(2):e003.

PMID: 39916685 PMC: 11783665. DOI: 10.1097/EA9.0000000000000003.


Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review.

Junior M, Sosa S, Fernandes M, do Carmo L, de Oliveira R, Kanevsky G BMC Pregnancy Childbirth. 2024; 24(1):830.

PMID: 39707247 PMC: 11660609. DOI: 10.1186/s12884-024-07044-3.


Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort.

Gilstrop Thompson M, Xu W, Moore B, Wang T, Sun N, Pewar H Obstet Gynecol. 2024; 145(2):211-216.

PMID: 39591628 PMC: 11731044. DOI: 10.1097/AOG.0000000000005794.


[Cell salvage in obstetrics-Background and practical implementation].

Kotlyar M, Neef V, Rumpf F, Meybohm P, Zacharowski K, Kranke P Anaesthesiologie. 2024; 73(12):843-851.

PMID: 39542885 PMC: 11615018. DOI: 10.1007/s00101-024-01479-1.


References
1.
Pegoraro V, Urbinati D, H A Visser G, Di Renzo G, Zipursky A, Stotler B . Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children. PLoS One. 2020; 15(7):e0235807. PMC: 7371205. DOI: 10.1371/journal.pone.0235807. View

2.
Okwundu C, Afolabi B . Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Cochrane Database Syst Rev. 2013; (1):CD007885. PMC: 11694612. DOI: 10.1002/14651858.CD007885.pub2. View

3.
Xie X, Fu Q, Bao Z, Zhang Y, Zhou D . Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis. PLoS One. 2020; 15(3):e0230073. PMC: 7067404. DOI: 10.1371/journal.pone.0230073. View

4.
Marcus R, Crewe-Brown H, Krawitz S, Katz J . Feto-maternal haemorrhage following successful and unsuccessful attempts at external cephalic version. Br J Obstet Gynaecol. 1975; 82(7):578-80. DOI: 10.1111/j.1471-0528.1975.tb00690.x. View

5.
Boucher M, Marquette G, Varin J, Champagne J, Bujold E . Fetomaternal hemorrhage during external cephalic version. Obstet Gynecol. 2008; 112(1):79-84. DOI: 10.1097/AOG.0b013e318179978c. View